Skip to main content
. 2022 Nov 18;23(22):14331. doi: 10.3390/ijms232214331
COVID-19 Coronavirus disease
PF Pulmonary fibrosis
FDA U.S. Food and Drug Administration
Pir Pirfenidone
Nin Nintedanib
TRF Tocotrienol-rich fractions
Carotene Natural Mixed-Carotene Complex 20% Oil Concentrate
TGF-β1 Transforming growth factor beta 1
IL-6 Interleukin-6
MPO Myeloperoxidase
IL-1β Interleukin-1β
TNFα Tumor necrosis factor-alpha
CAT Catalase
MDA Malondialdehyde
GSH Glutathione
NO Nitric oxide
SOD Superoxide dismutase
HE Hematoxylin-eosin
PBS Phosphate-buffered saline
SA/HRP Streptomyces ovalbumin working solution
DAB Diaminobenzidine
WB Western blot
ECL Enhanced chemiluminescence
PI3K Phosphatidylinositol 3-kinase
AKT Protein kinase B, PKB
mTOR Mammalian target of rapamycin
IFN-γ Interferonγ
IL-13 Interleukin-13
IkBα NF-kappa-B inhibitor alpha
Ikkβ Inhibitor of nuclear factor kappa-B kinase
ECM Excessive deposition of extracellular matrix